Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas

por Rebecca, Vito W., Xiao, Min, Kossenkov, Andrew, Godok, Tetiana, Brown, Gregory Schuyler, Fingerman, Dylan, Alicea, Gretchen M., Wei, Meihan, Ji, Hongkai, Bravo, Jeremy, Chen, Yeqing, Fane, Mitchell E., Villanueva, Jessie, Nathanson, Katherine, Liu, Qin, Gopal, Y. N. Vashisht, Davies, Michael A., Herlyn, Meenhard
Publicado 2023